In-vitro and in-vivo antibacterial activity of LB10517, a novel catechol-substituted cephalosporin with a broad antibacterial spectrum

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 4, 1996, Pages 711-726

  Song, Hye Kyoung ^a   Oh, Jeong In ^a   Kim, Mu Yong ^a   Kim, Yong Zu ^a   Kim, In Chull ^a   Kwak, Jin Hwan ^a  

^a LG Chemical Ltd   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CEFPIROME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; LB 10517; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG HYDROLYSIS; DRUG STABILITY; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENTEROCOCCUS FAECALIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; SEPTICEMIA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PYOGENES;

ANIMALS; BETA-LACTAMASES; CEPHALOSPORINS; DRUG RESISTANCE, MICROBIAL; DRUG STABILITY; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICE; MICROBIAL SENSITIVITY TESTS;

EID: 0029915157     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.4.711     Document Type: Article

References (28)

1. Arisawa, M., Sekine, Y., Shimizu, S., Takano, H., Angehrn, P. & Then, R. L. (1991). In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity. Antimicrobial Agents and Chemotherapy 35, 653-9.
2. Arnould, J. C., Bertrandie, A., Bird, T. G. C., Boucherot, D., Jung, F., Lohmann, J. J. et al. (1992). Synthesis and structure-activity relationships of cephalosporins with C-3′ catechol-containing residues. Journal of Medicinal Chemistry 35, 2631-42.
3. Aszodi, J., Humbert, D., Bonnefoy, A., Collette, P., Mauvais, P. & Chantot, J. F. (1994). RU59863, A novel catechol-substituted vinylogous cephalosporin: in vitro antibacterial activity. In Program and Abstracts of the Thirty-Fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, 1994. Abstract F99, p. 161. American Society for Microbiology, Washington, DC.
4. Bliss, C. I. (1952). The Statistics of Bioassay. Academic Press, New York.
5. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72, 248-54.
6. Bush, K., Jacoby, G. A. & Medeiros, A. A. (1995). A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrobial Agents and Chemotherapy 39, 1211-33.
7. Curtis, N. A. C., Eisenatadt, R. L., East, S. J., Cornford, R. J., Walker, L. A. & White, A. J. (1988). Iron-regulated outer membrane proteins of Escherichia coli K-12 and mechanism of action of catechol-substituted cephalosporins. Antimicrobial Agents and Chemotherapy 32, 1879-86.
8. Erwin, M. E., Jones, R. N., Barrett, M. S., Briggs, B. M. & Johnson, D. M. (1991). In vitro evaluation of GR 69153, a novel catechol-substituted cephalosporin. Antimicrobial Agents and Chemotherapy 35, 929-37.
9. Hartmann, A. & Braun, V. (1980). Iron transport in Escherichia coli: Uptake and modification of ferrichrome. Journal of Bacteriology 143, 246-55.
10. Jones, R. N. & Erwin, M. E. (1992). In vitro evaluation of Ro 09-1227, a novel catechol-substituted cephalosporin. Antimicrobial Agents and Chemotherapy 36, 233-8.
11. Kim, M. Y., Oh, J. I., Song, H. K., Baek, K. S. & Kwak, J. H. (1995). Prevalence of strains resistant to the third generation cephalosporins among clinical isolates and identification of TEM type β-lactamase from resistant strains by PCR method. Yakhak Hoeji, 39, 276-82.
12. Kobayashi, S., Arai, S., Hayashi, S. & Fujimoto, K. (1986). β-lactamase stability of cefpirome (HR810), a new cephalosporin with a broad antimicrobial spectrum. Antimicrobial Agents and Chemotherapy 30, 713-8.
13. Kolek, B., Fung-Tomc, J., Minassian, B., Flamm, R., Kessler, R. E. & Bonner, D. P. (1994). In vitro activity of a novel catechol - containing monobactam, BMS-180680. In vitro activity of a novel catechol - containing monobactam, BMS-180680. In Program and Abstracts of the Thirty-Fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, 1994. Abstract F143, p. 202. American Society for Microbiology, Washington, DC.
14. Kwak, J. H., Oh, J. I., Song, H. K., Kim, S. I., Kim, J. H., Kim, M. Y. et al. (1994). In vitro and in vivo activities of LK10517, a novel catechol-substituted cephalosporin. In Program and Abstracts of the Thirty-Fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, 1994. Abstract F93, p. 160. American Society for Microbiology, Washington, DC.
15. Maejima, T., Inoue, M. & Mitsuhashi, S. (1991). In vitro antibacterial activity of KP-736, a new cephem antibiotic. Antimicrobial Agents and Chemotherapy, 35, 104-10.
16. Mochida, K., Shiraki, C., Yamasaki, M. & Hirata, T. (1987). Aminothiazolylglycyl derivatives of carbapenems I. Synthesis and antibacterial activity of novel carbacephems with substituted aminothiazolyl groups. Journal of Antibiotics 40, 14-21.
17. Mochizuki, H., Yamada, H., Oikawa, Y., Murakami, K., Ishiguro, J., Kosuzume, H. et al. (1988). Bactericidal activity of M14659 enhanced in low-iron environments. Antimicrobial Agents and Chemotherapy 32, 1648-54.
18. Nakagawa, S., Sanada, M., Matsuda, K., Hashizume, T., Asahi, Y., Ushijima, R. et al. (1989). In vitro and in vivo antibacterial activities of BO-1341, a new antipseudomonal cephalosporin. Antimicrobial Agents and Chemotherapy 33, 1423-7.
19. Nakagawa, S., Sanada, M., Matsuda, K., Hazumi, N. & Tanaka, N. (1987). Biological activity of BO-1236, a new antipseudomonal cephalosporin. Antimicrobial Agents and Chemotherapy 31, 1100-5.
20. National Committee for Clinical Laboratory Standards. (1992). Methods for Determining Bactericidal Activity of Antimicrobial Agents, M26-T. NCCLS, Villanova, PA.
21. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Third Edition; Approved Standard M7-A3. NCCLS, Villanova, PA.
22. Ogino, H., Iwamatsu, K., Katano, K., Nakabayashi, S., Yoshida, T., Tsuruoka, T. et al. (1990). New aminothiazolyglyclcephalosporins with a 1,5-dihydroxy-4-pyridone-2-carbonyl group. I. Synthesis and biological activity of cephalosporin derivates leading to M0703. Journal of Antibiotics 43, 174-88.
23. Ohi, N., Aoki, B., Kuroki, T., Matsumoto, M., Kojima, K. & Nehashi, T. (1987). Semisynthetic β-lactam antibiotics. III. Effect on antibacterial activity and COMT-susceptibility of chlorine-introduction into the catechol nucleus. Journal of Antibiotics 40, 22-8.
24. Ohi, N., Aoki, B., Shinozaki, T., Moro, K., Noto, T., Nehashi, T. et al. (1986). Semisynthetic β-lactam antibiotics. I. Synthesis and antibacterial activity of new ureidopenicillin derivatives having catechol moieties. Journal of Antibiotics 39, 230-41.
25. Pollock, M. R. (1986). Purification and properties of penicillinase from two strains of Bacillus licheniformis: a chemical, physicochemical and physiological comparison. Biochemical Journal 94, 666-75.
26. Silley, P. Griffiths, J. W., Monsey, D. & Harris, A. M. (1990). Mode of action of GR69153, a novel catechol-substituted cephalosporin, and its interaction with the tonB-dependent iron transport system. Antimicrobial Agents and Chemotherapy 34, 1806-8.
27. Watanabe, N. A., Nagasu, T., Katsu, K. & Kitoh, K. (1987). E-0702, a new cephalosporin, is incorporated into Escherichia coli cells via the tonB-dependent iron transport system. Antimicrobial Agents and Chemotherapy 31, 497-504.
28. Wise, R., Andrews, J. M., Ashby, J. P. & Thornber, D. (1991). In vitro activity of a catechol-substituted cephalosporin, GR69153. Antimicrobial Agents and Chemotherapy 35, 329-34.